HD Visual Learning
Fundoscopic Exam Changes in Diabetic Retinopathy
Illustration of defining features associated with the classification of various stages of diabetic retinopathy
Inflammatory and VEGF Pathways Leading to the
Development of DR
Exploration of how inflammation and vascular endothelial growth factor (VEGF) contribute to the pathophysiology and subsequent destructive consequences of diabetic retinopathy
Visual Acuity and Treatment Timing
Visualization of the effects on visual acuity in diabetic retinopathy and neovascular age-related macular degeneration, as well as the impact that timely vs delayed treatment can have on vision.
Anti-VEGF therapy in DR, DME and AMD
Characterization of retinal pathology seen with diabetic retinopathy, diabetic macular edema and age-related macular degeneration, and the impact that anti-VEGF therapy can have on these changes.
Diabetic Retinopathy Pathophysiology
Description of the molecular pathogenesis of DR, which results in endothelial cell injury and death
Treatment of Diabetic Retinopathy
Exploration of available treatments for DR, including PRP and anti-VEGF therapies
A Visual Experience of the Diabetic Retinopathy Patient
Experience the visual changes of DR-affected eyes due to disease and treatment
The Inflammatory and VEGF Pathways of DR/DME
Investigate the cumulative effects of chronic hyperglycemia which lead to clinical retinopathy and macular edema
Stages of Diabetic Retinopathy Severity
Visualization of each stage of diabetic retinopathy severity using the International Clinical Disease Severity Scale
Fundoscopic Exam Changes in Diabetic Retinopathy
Illustration of defining features associated with the classification of various stages of diabetic retinopathy
Inflammatory and VEGF Pathways Leading to the
Development of DR
Visual Acuity and Treatment Timing
Visualization of the effects on visual acuity in diabetic retinopathy and neovascular age-related macular degeneration, as well as the impact that timely vs delayed treatment can have on vision.
Anti-VEGF therapy in DR, DME and AMD
Characterization of retinal pathology seen with diabetic retinopathy, diabetic macular edema and age-related macular degeneration, and the impact that anti-VEGF therapy can have on these changes.
Diabetic Retinopathy Pathophysiology
Description of the molecular pathogenesis of DR, which results in endothelial cell injury and death
Treatment of Diabetic Retinopathy
Exploration of available treatments for DR, including PRP and anti-VEGF therapies
A Visual Experience of the Diabetic Retinopathy Patient
Experience the visual changes of DR-affected eyes due to disease and treatment
The Inflammatory and VEGF Pathways of DR/DME
Investigate the cumulative effects of chronic hyperglycemia which lead to clinical retinopathy and macular edema
Stages of Diabetic Retinopathy Severity
Visualization of each stage of diabetic retinopathy severity using the International Clinical Disease Severity Scale
Anti-VEGF’s in DR, AMD and RVO
Augmented reality animation briefly describing the role of vascular endothelial grouth factor (VEGF) in the body’s normal healing response, the negative effects of overproduction of VEGF which can harm retinal tissue, and how anti-VEGF medications can help block the harmful effects of VEGF on the structures of the retina.
Click on the link below to navigate the symptom tool from your desktop or mobile phone:
Interactive mobile tool that allows you to easily navigate the most common symptoms of diabetic retinopathy (DR), age-related macular degeneration (AMD) and retinal vein occlusion (RVO), access clinical pearls of continued care for confirmed DR, AMD and RVO diagnoses, guidelines for timely eye exams, dedicated patient educational resources and links to locate nearby eye care providers.
Seeing Clearer in DR
Click on the link below to navigate to the swiper tool from your mobile phone:
Interactive mobile tool that allows you to ‘swipe’ through highlights of key concepts related to diabetic retinopathy, including pathologic retinal changes, at-risk populations and their associated times to DR development, the relationship between DR and HbA1c, recommended screening intervals, and indications for prompt specialist referral.
DR & PRP Therapy
Augmented reality animation briefly describing the treatment of diabetic retinopathy with panretinal photocoagulation (PRP) laser therapy, how it works, and associated benefits of treatment schedule and adverse effects of treatment including affect on visual fields, contrast sensitivity, night vision and color vision.
Diabetic Retinopathy
Augmented reality animation displaying the pathophysiologic changes observed within differing stages of diabetic retinopathy. Each stage of retinopathy is carefully described, matched to a visually engaging depiction of the associated developing retinal disease.
Seeing Clearer: An Immersive Simulation Experience in Diabetic Retinopathy
Engage in an interactive simulation in diabetic retinopathy, where information obtained during patient evaluation can be utilized to determine diagnosis and therapeutic approaches at various key points in care.
Seeing Beyond the Disease:
A Virtual Reality Room Experience of the Potential Burdens Related to Diabetic Retinopathy and Age-related Macular Degeneration
Examine the relationship between visual acuity and timeliness of treatment initiation, and how this can affect vision in diabetic macular edema, proliferative diabetic retinopathy and neovascular age-related macular degeneration, as well as vision-related quality of life outcomes, guided by Dr. Neil Bressler
No Eyes Left Behind: A Diabetic Retinopathy Virtual Reality Room Experience
Explore how hyperglycemia affects the retina at the cellular level, followed by targeted treatment options and a visual experience of the retinopathy patient, guided by Dr. Julia Haller
Beyond The Lens: A Diabetic Retinopathy and Macular Edema Virtual Reality Room Experience
Explore the pathologic pathways that can lead to retinopathy and macular edema, followed by a detailed visualization of each stage of severity, guided by Dr. Charles Wykoff
